Measures of growth in children at risk for Huntington disease

Neurology

Volumn 79, Issue 7, 2012, Pages 668-674

  Lee, Jessica K ^a   Mathews, Kathy ^a   Schlaggar, Bradley ^b,c   Perlmutter, Joel ^b,c   Paulsen, Jane S ^a,d   Epping, Eric ^a   Burmeister, Leon ^d   Nopoulos, Peg ^a  

^a UNIVERSITY OF IOWA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAIN DEVELOPMENT; BRAIN SIZE; CAG REPEAT; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HEAD CIRCUMFERENCE; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 84866082207     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182648b65     Document Type: Article

References (41)

1. Molero AE, Gokhan S, Gonzalez S, Feig JL, Alexandre LC, Mehler MF. Impairment of developmental stem cellmediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc Natl Acad Sci USA 2009;106:21900 -21905.
2. Nopoulos PC, Aylward EH, Ross CA, et al. Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. Brain 2011;134: 137-142.
3. Orth M, Cooper JM, Bates GP, Schapira AH. Inclusion formation in Huntington's disease R6/2 mouse muscle cultures. J Neurochem 2003;87:1- 6.
4. Bhide PG, Day M, Sapp E, et al. Expression of normal and mutant huntingtin in the developing brain. J Neurosci1996; 16:5523-5535.
5. Farrer LA, Yu PL. Anthropometric discrimination among affected, at-risk, and not-at-risk individuals in families with Huntington disease. Am J Med Genet 1985;21:307-316.
6. Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants. Neurology 2009;73:385-392.
7. Trejo A, Tarrats RM, Alonso ME, Boll MC, Ochoa A, Velasquez L. Assessment of the nutrition status of patients with Huntington's disease. Nutrition 2004;20:192-196.
8. Farrer LA, Meaney FJ. An anthropometric assessment of Huntington's disease patients and families. Am J Phys Anthropol 1985;67:185-194.
9. Aziz NA, van der Burg JM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RA. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology 2008;71:1506 -1513.
10. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-277.
11. Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group. Mov Disord 1996; 11:136 -142.
12. Hollingshead A, Redlich F. Social Class and Mental Illness: A Community Study. New York: John Wiley; 1958.
13. SAS Institute. SAS/STAT User's Guide. Cary, NC: SAS Institute; 2003.
14. Centers for Disease Control and Prevention. CDC Growth Charts: United States. Available at: http://www.cdc.gov/growthcharts/. Accessed June 2011.
15. Kuczmarski RJ, Ogden CL, Guo SS, et al. CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2000;2002:1-190.
16. Djousse L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH. Weight loss in early stage of Huntington's disease. Neurology 2002;59:1325-1330.
17. Robbins AO, Ho AK, Barker RA. Weight changes in Huntington's disease. Eur J Neurol 2006;13:e7.
18. Mochel F, Charles P, Seguin F, et al. Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS One 2007;2: e647.
19. Goodman AO, Murgatroyd PR, Medina-Gomez G, et al. The metabolic profile of early Huntington's disease-a combined human and transgenic mouse study. Exp Neurol 2008;210:691- 698.
20. Underwood BR, Broadhurst D, Dunn WB, et al. Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain 2006;129:877-886.
21. van der Burg JM, Bacos K, Wood NI, et al. Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 2008;29:41-51.
22. Damiano M, Galvan L, Deglon N, Brouillet E. Mitochondria in Huntington's disease. Biochim Biophys Acta 2010; 1802:52- 61.
23. Oliveira JM. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J Neurochem 2010;114:1-12.
24. Powers WJ, Videen TO, Markham J, et al. Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc Natl Acad Sci USA 2007;104:2945-2949.
25. Mochel F, Haller RG. Energy deficit in Huntington disease: why it matters. J Clin Invest 2011;121:493- 499.
26. Rosenstock TR, Duarte AI, Rego AC. Mitochondrialassociated metabolic changes and neurodegeneration in Huntington's disease: from clinical features to the bench. Curr Drug Targets 2010;11:1218 -1236.
27. Orr AL, Li S, Wang CE, et al. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 2008;28:2783-2792.
28. Chang DT, Rintoul GL, Pandipati S, Reynolds IJ. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 2006; 22:388-400.
29. Turner C, Cooper JM, Schapira AH. Clinical correlates of mitochondrial function in Huntington's disease muscle. Mov Disord 2007;22:1715-1721.
30. Singh GK. Childhood Obesity in the United States, 1976-2008: Trends and Current Racial/Ethnic, Socioeconomic, and Geographic Disparities: A 75th Anniversary Publication: Maternal and Child Health Bureau. Rockville, MD: US Department of Health and Human Services; 2010.
31. Silventoinen K, Sammalisto S, Perola M, et al. Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Res 2003;6:399-408.
32. Visscher PM, Medland SE, Ferreira MA, et al. Assumptionfree estimation of heritability from genome-wide identity-bydescent sharing between full siblings. PLoS Genet 2006;2: e41.
33. Gerald LB, Anderson A, Johnson GD, Hoff C, Trimm RF. Social class, social support and obesity risk in children. Child Care Health Dev 1994;20:145-163.
34. Lamerz A, Kuepper-Nybelen J, Wehle C, et al. Social class, parental education, and obesity prevalence in a study of six-year-old children in Germany. Int J Obes 2005;29: 373-380.
35. Dunger DB, Ahmed ML, Ong KK. Early and late weight gain and the timing of puberty. Mol Cell Endocrinol 2006;254 -255:140 -145.
36. Buchan IE, Bundred PE, Kitchiner DJ, Cole TJ. Body mass index has risen more steeply in tall than in short 3-year olds: serial cross-sectional surveys 1988-2003. Int J Obes 2007;31:23-29.
37. Murasko JE. Socioeconomic status, height, and obesity in children. Econ Hum Biol 2009;7:376 -386.
38. Bartholomeusz HH, Courchesne E, Karns CM. Relationship between head circumference and brain volume in healthy normal toddlers, children, and adults. Neuropediatrics 2002;33:239 -241.
39. Bray PF, Shields WD, Wolcott GJ, Madsen JA. Occipitofrontal head circumference-an accurate measure of intracranial volume. J Pediatr 1969;75:303-305.
40. Courchesne E, Chisum HJ, Townsend J, et al. Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 2000; 216:672- 682.
41. Moss ML, Salentijn L. The primary role of functional matrices in facial growth. Am J Orthod 1969;55:566 -577.